Skip to content

Telecoaching of People With Type 2 Diabetes in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01612520
Enrollment
574
Registered
2012-06-06
Start date
2012-04-30
Completion date
2015-01-31
Last updated
2015-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Telenursing, Type 2 Diabetes Mellitus

Keywords

type 2 Diabetes Mellitus, telenursing, RCT, economic analysis

Brief summary

The objective of the study is to analyze the effectiveness and the cost-effectiveness of telecoching in improving glyceamic control and other modifiable risk factors in patients with type 2 diabetes compared to usual care only.

Interventions

BEHAVIORALtelecoaching

The COACH program trains patients to 'drive' the process of achieving and maintaining the target levels for their risk factors while working in association with their GP. The telephone coaching is aimed at improving self-efficacy by adhering to the prescribed therapy and making relevant behavior changes. The coaching model is a continuous five-stage coaching cycle: Stage 1. Finding out what the patient knows; Stage 2. Telling the patient what they should know; Stage 3. Assertiveness training; Stage 4. Setting an action plan; Stage 5. Reassessment at the next coaching session (monitoring). The coach monitors and registers: the biomedical risk factors, the lifestyle/behavioral risk factors and use of the recommended medications. Coaching is focused on eliminating the knowledge gap and motivating the patient to apply the appropriate lifestyle and medical therapy.

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* patients with type 2 diabetes between 18 and 75 years old on the day of the selection

Exclusion criteria

* Debilitating coexisting medical condition (e.g. dialysis, mental illness, cancer) * Residents of long term care facilities * Pregnancy * Incapable of telephone communication in Dutch

Design outcomes

Primary

MeasureTime frame
the absolute change in HbA1cbaseline; 6 months and 18 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026